NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,093,445 | -2.9% | 295,439 | -3.8% | 0.03% | 0.0% |
| Q2 2023 | $30,995,430 | +8.3% | 307,159 | -1.3% | 0.03% | +4.0% |
| Q1 2023 | $28,629,573 | -2.3% | 311,191 | -3.7% | 0.02% | -10.7% |
| Q4 2022 | $29,305,355 | +8.7% | 323,031 | -8.9% | 0.03% | 0.0% |
| Q3 2022 | $26,963,000 | -9.5% | 354,736 | +0.6% | 0.03% | -3.4% |
| Q2 2022 | $29,801,000 | -7.4% | 352,543 | -3.8% | 0.03% | +3.6% |
| Q1 2022 | $32,174,000 | -5.3% | 366,653 | -5.6% | 0.03% | 0.0% |
| Q4 2021 | $33,968,000 | +24.5% | 388,344 | +16.4% | 0.03% | +12.0% |
| Q3 2021 | $27,287,000 | -11.5% | 333,665 | -1.2% | 0.02% | -10.7% |
| Q2 2021 | $30,818,000 | +3.9% | 337,792 | -2.7% | 0.03% | -3.4% |
| Q1 2021 | $29,671,000 | -9.8% | 347,109 | -0.4% | 0.03% | -12.1% |
| Q4 2020 | $32,907,000 | +3.3% | 348,487 | -4.9% | 0.03% | -15.4% |
| Q3 2020 | $31,871,000 | -2.5% | 366,505 | -2.1% | 0.04% | -11.4% |
| Q2 2020 | $32,704,000 | +1.7% | 374,440 | -4.0% | 0.04% | +10.0% |
| Q1 2020 | $32,159,000 | -13.7% | 390,064 | -0.9% | 0.04% | +8.1% |
| Q4 2019 | $37,278,000 | +7.0% | 393,687 | -1.8% | 0.04% | +5.7% |
| Q3 2019 | $34,826,000 | -5.8% | 400,748 | -1.0% | 0.04% | -2.8% |
| Q2 2019 | $36,967,000 | -6.0% | 404,855 | -1.0% | 0.04% | -7.7% |
| Q1 2019 | $39,309,000 | +9.2% | 408,890 | -2.5% | 0.04% | -2.5% |
| Q4 2018 | $35,989,000 | -2.0% | 419,399 | -1.6% | 0.04% | +14.3% |
| Q3 2018 | $36,733,000 | +12.2% | 426,341 | -1.6% | 0.04% | +9.4% |
| Q2 2018 | $32,743,000 | -8.1% | 433,461 | -1.6% | 0.03% | -8.6% |
| Q1 2018 | $35,614,000 | -7.3% | 440,515 | -3.8% | 0.04% | -5.4% |
| Q4 2017 | $38,427,000 | -3.8% | 457,683 | -1.6% | 0.04% | -9.8% |
| Q3 2017 | $39,925,000 | -1.3% | 465,059 | -4.0% | 0.04% | -4.7% |
| Q2 2017 | $40,433,000 | +7.7% | 484,410 | -4.2% | 0.04% | +2.4% |
| Q1 2017 | $37,538,000 | -11.1% | 505,431 | -12.8% | 0.04% | -12.5% |
| Q4 2016 | $42,216,000 | -5.9% | 579,571 | +2.0% | 0.05% | -7.7% |
| Q3 2016 | $44,882,000 | -4.9% | 568,411 | -0.6% | 0.05% | -5.5% |
| Q2 2016 | $47,181,000 | +8.6% | 571,824 | -4.7% | 0.06% | +7.8% |
| Q1 2016 | $43,450,000 | -19.4% | 599,805 | -4.3% | 0.05% | -20.3% |
| Q4 2015 | $53,921,000 | -16.1% | 626,716 | -10.4% | 0.06% | -16.9% |
| Q3 2015 | $64,274,000 | -7.9% | 699,239 | -1.4% | 0.08% | -1.3% |
| Q2 2015 | $69,758,000 | -1.7% | 709,365 | -1.5% | 0.08% | 0.0% |
| Q1 2015 | $70,997,000 | +10.9% | 719,969 | +4.2% | 0.08% | +11.4% |
| Q4 2014 | $64,006,000 | +0.9% | 690,756 | +2.5% | 0.07% | -6.7% |
| Q3 2014 | $63,438,000 | +21.1% | 673,937 | +16.5% | 0.08% | +11.9% |
| Q2 2014 | $52,382,000 | +4.3% | 578,636 | -2.1% | 0.07% | +1.5% |
| Q1 2014 | $50,240,000 | +2.9% | 590,912 | -2.7% | 0.07% | +1.5% |
| Q4 2013 | $48,808,000 | -0.6% | 607,215 | -5.1% | 0.06% | -9.7% |
| Q3 2013 | $49,097,000 | +5.5% | 640,027 | -2.8% | 0.07% | +5.9% |
| Q2 2013 | $46,553,000 | – | 658,363 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |